PharmaCielo: Largest Grower in the World

PharmaCielo Ltd. is a global, publicly traded company headquartered in Canada. The Company focuses on ethical and sustainable processing and supplying …

PharmaCielo cannabis producer

A Canadian company with Colombian operations

PharmaCielo Ltd. is a global, publicly traded company headquartered in Canada. The Company focuses on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is GLOBAL G.A.P.-certified PharmaCielo Colombia Holdings S.A.S. The headquarters are at its nursery and propagation centre located in Rionegro, Colombia.

Moreover, PharmaCielo is the first company to hold Colombian licences for cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD). Markedly, this has made them the world’s largest licensed producer.

Additionally, their medicinal-grade oil extracts and related products provide reliable, standardized relief and wellness formulas for patients in need, including those requiring higher levels of THC.

Why Colombia?

PharmaCielo chose Colombia as its operational base for its outstanding climatic and economic conditions. This includes its history in the cut-flower industry, as well as its clear legal framework for cannabis licensing.

Furthermore, the Colombian climate fosters open-air greenhouse propagation allowing cannabis to grow without any additives or simulated conditions. PharmaCielo only uses real rainwater and sunlight. And it’s even more environmentally friendly because the plants absorb carbon dioxide and release oxygen.

For more information on PharmaCielo Ltd. (PCLO:TSX.V, PCLOF:OTCQX) please fill out the form below.

You might also like

Ivan Bebek on Where the Biggest Mining Returns May Still Lie
Metals & Mining
March 4, 2026

Ivan Bebek on Where the Biggest Mining Returns May Still Lie

Veteran mining entrepreneur Ivan Bebek believes the current gold and silver cycle may only be getting started.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs
ETFs
March 3, 2026

BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs

In Canada, management fees for asset allocation ETFs can range from approximately 50 basis points down to 15 basis points.

This is some text inside of a div block.
Subscribe and receive the investor Info